Back
Design Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
DSGN
Design Therapeutics, Inc.
Last Price:
$9.60
Seasonality Move:
-15.75%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGN is experiencing slight buying pressure.
Design Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.37 | Buy |
| 20-day SMA: | 9.38 | Buy |
| 50-day SMA: | 7.81 | Buy |
| 200-day SMA: | 5.35 | Buy |
| 8-day EMA: | 9.46 | Buy |
| 20-day EMA: | 9.12 | Buy |
| 50-day EMA: | 8.15 | Buy |
| 200-day EMA: | 6.12 | Buy |
Design Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 62.52 | Buy |
| Chaikin Money Flow: | 286963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.28 - 9.8) | Buy |
| Bollinger Bands (100): | (5.2 - 8.34) | Buy |
Design Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Design Therapeutics, Inc. Stock
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.96 while DSGN 8-day simple moving average is 9.37, which is a Buy signal.
-
The stock price of DSGN is 9.96 while Design Therapeutics, Inc. 20-day SMA is 9.38, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day simple moving average is 7.81 while DSGN share price is 9.96, making it a Buy technically.
-
DSGN stock price is 9.96 and Design Therapeutics, Inc. 200-day simple moving average is 5.35, creating a Buy signal.
DSGN Technical Analysis vs Fundamental Analysis
Buy
57
Design Therapeutics, Inc. (DSGN)
is a Buy
Is Design Therapeutics, Inc. a Buy or a Sell?
-
Design Therapeutics, Inc. stock is rated a BuyThe current Design Therapeutics, Inc. [DSGN] share price is $9.96. The Score for DSGN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Design Therapeutics, Inc. Stock Info
Market Cap:
567.4M
Price in USD:
9.96
Share Volume:
791.3K
Design Therapeutics, Inc. 52-Week Range
52-Week High:
10.31
52-Week Low:
2.60
Buy
57
Design Therapeutics, Inc. (DSGN)
is a Buy
Design Therapeutics, Inc. Share Price Forecast
-
What is the Design Therapeutics, Inc. stock price today?The Design Therapeutics, Inc. stock price is 9.96 USD today.
-
Will DSGN stock go up or go down?Design Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Design Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Design Therapeutics, Inc. is not overvalued.
Is Design Therapeutics, Inc. Stock a Buy?
-
Design Therapeutics, Inc. share price is 9.96 while DSGN 8-day exponential moving average is 9.46, which is a Buy signal.
-
The stock price of DSGN is 9.96 while Design Therapeutics, Inc. 20-day EMA is 9.12, which makes it a Buy.
-
Design Therapeutics, Inc. 50-day exponential moving average is 8.15 while DSGN share price is 9.96, making it a Buy technically.
-
DSGN stock price is 9.96 and Design Therapeutics, Inc. 200-day simple moving average is 6.12, creating a Buy signal.
Fundamental Analysis of Design Therapeutics, Inc.
Is Design Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Design Therapeutics, Inc.
Should I short Design Therapeutics, Inc. stock?
-
DSGN Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Design Therapeutics, Inc. is a Buy
-
Design Therapeutics, Inc. Relative Strength Index (RSI) is 62.52, which suggest Design Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Design Therapeutics, Inc. is (8.28 - 9.8), which suggest Design Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Design Therapeutics, Inc. is (5.2 - 8.34), which suggest Design Therapeutics, Inc. is a Buy
* Design Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.